Biogen Idec, Inc. (BIIB) Misses Q4 EPS by 6c; Guides FY13 EPS Below Views
Tweet Send to a FriendGet Alerts BIIB Hot Sheet
Price: $203.80 -3.32%
EPS Growth %: +40.7%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: -480.84M
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: +40.7%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: -480.84M
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade BIIB Now!
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q4 EPS of $1.40, $0.06 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.38 billion.
Sees FY2013 EPS of $7.15 - $7.25, versus the consensus of $7.27. Sees revs up about 10 percent.
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY2013 EPS of $7.15 - $7.25, versus the consensus of $7.27. Sees revs up about 10 percent.
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- GenMark Diagnostics (GNMK) Warns for FY2013
- United Tech (UTX) to Pay $473M in F100 Engine Litigation; Sees Possible Material Impact
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
